Resources from the same session
357MO - Comparison of long-term quality of life between survivors of adolescent and adult nasopharyngeal carcinoma
Presenter: Liting Liu
Session: Mini oral session: Head and neck cancer
Resources:
Abstract
Slides
Webcast
358MO - Quality-adjusted life-year and life-year estimates for patients with recurrent/metastatic squamous cell carcinoma of the head and neck in the combined positive score 1-19 subgroup treated with pembrolizumab +/- chemotherapy vs cetuximab-containing regimens
Presenter: Philipp Ivanyi
Session: Mini oral session: Head and neck cancer
Resources:
Abstract
Slides
Webcast
Q&A and discussion
Presenter: All Speakers
Session: Mini oral session: Head and neck cancer
Resources:
Webcast
359MO - Phase I dose-escalation study of nab-paclitaxel combined with cisplatin and capecitabin as induction chemotherapy followed by concurrent chemoradiotherapy in patients with nasopharyngeal carcinoma
Presenter: Shan-Shan Guo
Session: Mini oral session: Head and neck cancer
Resources:
Abstract
Slides
Webcast
360MO - Pembrolizumab plus nab-paclitaxel and platinum as first-line treatment in patients with recurrent or metastatic head and neck squamous-cell carcinoma (R/M HNSCC): A prospective phase II study
Presenter: Xinrui Chen
Session: Mini oral session: Head and neck cancer
Resources:
Abstract
Slides
Webcast
361MO - Characterizing the role of NSD family of histone methyltransferases in the head and neck squamous cell carcinoma tumor immune microenvironment
Presenter: Yanis Boumber
Session: Mini oral session: Head and neck cancer
Resources:
Abstract
Slides
Webcast
Invited Discussant 359MO, 360MO and 361MO
Presenter: Bhumsuk Keam
Session: Mini oral session: Head and neck cancer
Resources:
Slides
Webcast
Q&A and discussion
Presenter: All Speakers
Session: Mini oral session: Head and neck cancer
Resources:
Webcast